Pharmaceutical Compositions for the Treatment of Capillary Arteriopathy
    2.
    发明申请
    Pharmaceutical Compositions for the Treatment of Capillary Arteriopathy 有权
    用于治疗毛细血管病变的药物组合物

    公开(公告)号:US20140045879A1

    公开(公告)日:2014-02-13

    申请号:US13354832

    申请日:2012-01-20

    IPC分类号: C07D471/06

    摘要: The present invention relates to the use of ergot derivatives or ergolines, and in particular of lisuride and terguride for the prophylaxis and treatment of constrictive capillary arteriopathy. Constrictive capillary arteriopathy refers to the diseases pulmonary arterial hypertension, endogenously induced or exogenously induced glomeruloscleroses as well as secondary Raynaud's syndrome.

    摘要翻译: 本发明涉及麦角衍生物或麦角蛋白,特别是利鲁司特和替麦格德用于预防和治疗缩窄性毛细血管病变的用途。 狭窄性毛细血管动脉病是指肺动脉高压,内源诱导或外源性诱导的肾小球硬化以及继发性雷诺综合征的疾病。

    Process for the production of semisolid preparations containing
micronized active ingredients
    5.
    发明授权
    Process for the production of semisolid preparations containing micronized active ingredients 失效
    生产含有微粉化活性成分的半固体制剂的方法

    公开(公告)号:US5432170A

    公开(公告)日:1995-07-11

    申请号:US66077

    申请日:1993-05-17

    摘要: A process for the production of semisolid preparations containing micronized active ingredients is described which is characterized in that a mixture of one or two nonionic surfactants with an HLB of 9 to 18 with 2.3 to 100 times the amount by weight of a fatty acid ester of general formulaR.sub.1 --COO--R.sub.2in which R.sub.1 and R.sub.2 each represent alkyl groups or alkenyl groups with 12 to 32 carbon atoms, or a mixture of these fatty acid esters is heated until it melts, the melt with stirring is put into 10 to 200 times the amount by weight of a semisolid preparation, which is heated approximately to the same temperature, the mixture is allowed to cool with stirring and mixed with the micronized active ingredient or active ingredient mixture as well as optionally with scents.

    摘要翻译: PCT No.PCT / DE91 / 00593 Sec。 371日期:1993年5月17日 102(e)日期1993年5月17日PCT提交1991年7月16日PCT公布。 公开号WO93 / 01836 日本2月4日,日本专利文献1:一种制备含有微粉化活性成分的半固体制剂的方法,其特征在于一种或两种HLB为9-18的非离子表面活性剂的混合物,其重量为2.3-100倍 的通式为R 1 -COO-R 2的脂肪酸酯,其中R 1和R 2各自表示具有12至32个碳原子的烷基或链烯基,或这些脂肪酸酯的混合物加热直至熔融,同时搅拌 加入到约为相同温度的半固体制剂重量的10至200倍,将混合物搅拌冷却并与微粉化的活性成分或活性成分混合物以及任选的香料混合 。

    Agent containing ergoline for transdermal application
    6.
    发明申请
    Agent containing ergoline for transdermal application 审中-公开
    含麦角林的药物用于经皮应用

    公开(公告)号:US20070134309A1

    公开(公告)日:2007-06-14

    申请号:US10570262

    申请日:2004-05-30

    IPC分类号: A61K9/70

    摘要: The invention relates to a transdermal therapeutic system containing ergolin compounds, preferably lisuride, in which the ergolin compound is stabilized. The oxidation-sensitive ergolin compound is stabilized by a combination of at least one liposoluble, free radical-scavenging antioxidant, preferably di-tert.-butyl methyl phenol, di-tert.-butyl metoxy phenol, tocopherol or ubiquinone and a basic polymer.

    摘要翻译: 本发明涉及一种含有麦角蛋白化合物,优选碘化镧的透皮治疗系统,其中麦角蛋白化合物稳定化。 氧化敏感的麦角蛋白化合物通过至少一种脂溶性自由基清除抗氧化剂,优选二叔丁基甲基苯酚,二叔丁基甲氧基苯酚,生育酚或泛醌和碱性聚合物的组合来稳定。

    Preparation comprising cavitate-  or clathrate-forming host/guest
complexes as contrast agent
    7.
    发明授权
    Preparation comprising cavitate- or clathrate-forming host/guest complexes as contrast agent 失效
    包含形成空化或笼形化的宿主/客体配合物作为造影剂的制备

    公开(公告)号:US5730954A

    公开(公告)日:1998-03-24

    申请号:US322966

    申请日:1994-10-13

    CPC分类号: B82Y5/00 A61K49/18 A61K49/228

    摘要: A method of using cavitate- or clathrate-forming host/guest complexes for the preparation of contrast media in ultrasonic examination is provided. The host/guest complexes have a host which dissolves in a liquid carrier, releasing the guest (inert gas). With such contrast media, it is possible to diagnose blood and its flow conditions in the heart, and other organs, such as the myocardium, liver, spleen, and kidneys. Other internal systems such as the urinary ducts, the gastrointestinal tract, joints, and eyes can also be imaged.

    摘要翻译: 提供了一种在超声检查中使用空化或笼形物形成宿主/客体复合物制备造影剂的方法。 主体/客体配合物具有溶解在液体载体中的主体,释放客体(惰性气体)。 使用这样的造影剂,可以诊断心脏和其他器官如心肌,肝脏,脾脏和肾脏中的血液及其流动状况。 其他内部系统,例如尿管,胃肠道,关节和眼睛也可以成像。

    Medicinal agents with sustained action
    8.
    发明授权
    Medicinal agents with sustained action 失效
    具有持续作用的药物

    公开(公告)号:US5286494A

    公开(公告)日:1994-02-15

    申请号:US715699

    申请日:1991-06-17

    IPC分类号: A61K9/50 A61K9/54 A61K9/16

    摘要: Medicinal agents are claimed exhibiting sustained release of active compound, containing a solid active ingredient, poorly soluble in water, and auxiliary agents, characterized in that the active compound, in a microcrystalline form or in form of a molecular dispersion, is distributed in or on pellets, and that the pellets are covered by a membrane having retarded permeability with respect to the active compound.

    摘要翻译: 药物剂要求显示持续释放的活性化合物,其含有固体活性成分,难溶于水和辅助剂,其特征在于微晶形式或分子分散体形式的活性化合物分布在 颗粒,并且颗粒被相对于活性化合物具有延迟渗透性的膜覆盖。

    GRINDING BODY
    9.
    发明申请
    GRINDING BODY 审中-公开
    研磨体

    公开(公告)号:US20130295827A1

    公开(公告)日:2013-11-07

    申请号:US13980705

    申请日:2012-01-17

    申请人: Johannes Tack

    发明人: Johannes Tack

    IPC分类号: B24D11/00

    CPC分类号: B24D11/00 B24D3/346

    摘要: A grinding body (1), which consists of a support material (5) and an abrasive (2) adhesively applied thereto, is formed such that the grinding body (1) has an abrasive-free rim that laterally adjoins the active region of the abrasive (2).

    摘要翻译: 形成有由支撑材料(5)和粘合地施加到其上的研磨剂(2)组成的研磨体(1),使得研磨体(1)具有无磨擦的边缘,其横向邻接于 磨料(2)。